Home › Funds › Omega Fund Management, LLC › ENGN
Omega Fund Management, LLC position in ENGN
ENGENE THERAPEUTICS INC · Health Care
Omega Fund Management, LLC reported holding 876,357 shares of ENGN (ENGENE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.5M, representing 0.82% of its reported portfolio and ranking #9 among its reported holdings. Omega Fund Management, LLC has disclosed ENGN holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Omega Fund Management, LLC's ENGN position evolved
Omega Fund Management, LLC first disclosed a stake in ENGN in Q4 2023 at 1,131,175 shares (US$10.4M). The position peaked in Q1 2024 at 1,076,357 shares, worth US$18.2M. Across 11 filings, Omega Fund Management, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 876,357 shares valued at US$1.5M. Notable position changes include a 51% trim in Q4 2024 (shares fell 33% over the following quarter), a 66% increase in Q4 2025 (shares fell 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 1.13M | $10.44M | New |
| Q1 2024 | 1.08M | $18.24M | Reduce |
| Q2 2024 | 1.08M | $10.15M | Hold |
| Q3 2024 | 1.08M | $7.10M | Hold |
| Q4 2024 | 526.36K | $3.50M | Reduce |
| Q1 2025 | 526.36K | $2.36M | Hold |
| Q2 2025 | 526.36K | $1.92M | Hold |
| Q3 2025 | 526.36K | $3.60M | Hold |
| Q4 2025 | 876.36K | $7.91M | Add |
| Q1 2026 | 876.36K | $5.97M | Hold |
| Q2 2026 | 876.36K | $1.52M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ENGN and 13F data
ENGN (ENGENE THERAPEUTICS INC) is a Health Care company. 32 other funds we track also report a position in ENGN — the largest reported positions include FCPM III SERVICES B.V. (US$16.7M), BML Capital Management, LLC (US$11.5M), Nextech Invest Ltd. (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ENGN
- FCPM III SERVICES B.V. 9.63M sh · $16.66M · Q2 2026
- BML Capital Management, LLC 6.67M sh · $11.54M · Q2 2026
- Nextech Invest Ltd. 2.32M sh · $4.02M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 1.27M sh · $2.20M · Q2 2026
- Peapod Lane Capital LLC 1.04M sh · $2.08M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 747.75K sh · $1.29M · Q2 2026
- Kynam Capital Management, LP 457.86K sh · $792.09K · Q2 2026
- Elmind Capital, LP 210.00K sh · $363.30K · Q2 2026
More on Omega Fund Management, LLC
FAQ
How long has Omega Fund Management, LLC held ENGN?
Omega Fund Management, LLC has disclosed ENGN holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is Omega Fund Management, LLC's current position in ENGN?
As of Q2 2026, Omega Fund Management, LLC holds 876.36K shares of ENGN (ENGENE THERAPEUTICS INC), valued at $1.52M, representing 0.82% of its reported portfolio and ranking #9.
Has Omega Fund Management, LLC been buying or selling ENGN?
In the latest 13F filing (Q2 2026), Omega Fund Management, LLC held unchanged its position in ENGN. The position peaked in Q1 2024 at 1.08M shares.
Which other funds hold ENGN?
Other major institutional holders of ENGN include FCPM III SERVICES B.V., BML Capital Management, LLC, Nextech Invest Ltd., among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.